The discovery of this quadruple (PDGFA–PDGFRA–CREB1–PLAT), capable of distinguishing between grade III and grade IV gliomas, holds substantial implications for patients affected by these tumors. This evidence concerns the gene PDGFA and central nervous system cancer.